The Series B financing round of HVR Cardio was led by Finnish Innovestor Life Science Fund and Tesi.
The Finnish cardiovascular device company HVR Cardio is developing a catheter-based solution CathHELIX, which makes it possible to repair the fault without the need for demanding open-heart sur